Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA - FMS Price Target & Analyst Ratings

$15.59
+0.24 (+1.56%)
(As of 11/25/2022 08:57 PM ET)
Add
Compare
Today's Range
$15.44
$15.63
50-Day Range
$12.81
$16.50
52-Week Range
$12.78
$35.04
Volume
274,500 shs
Average Volume
835,088 shs
Market Capitalization
$9.14 billion
P/E Ratio
11.06
Dividend Yield
3.14%
Price Target
$38.16

Fresenius Medical Care AG & Co. KGaA Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 9 Analyst Ratings

Consensus Analyst Price Target

$30.35
94.68% Upside
High Prediction$33.70
Average Prediction$30.35
Low Prediction$27.00
TypeCurrent
11/28/21 to 11/28/22
1 Month Ago
10/29/21 to 10/29/22
3 Months Ago
8/30/21 to 8/30/22
1 Year Ago
11/28/20 to 11/28/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
6 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
13 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$30.35$31.90$31.90$37.50
Predicted Upside94.68% Upside25.85% Upside13.08% Upside10.44% Upside
Get Fresenius Medical Care AG & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.


FMS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fresenius Medical Care AG & Co. KGaA Stock vs. The Competition

TypeFresenius Medical Care AG & Co. KGaAMedical CompaniesS&P 500
Consensus Rating Score
1.89
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside94.68% Upside748.84% Upside12.77% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
378
53.39%
Underperform Votes
330
46.61%
Avg. Outperform Votes
162
66.39%
Avg. Underperform Votes
82
33.61%
Avg. Outperform Votes
851
68.13%
Avg. Underperform Votes
398
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/9/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target€37.00 ➝ €32.00
11/3/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell ➝ Sell€24.00 ➝ €22.00
11/2/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight€34.00 ➝ €33.00
11/1/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target€23.00 ➝ €17.10
10/28/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight€40.00 ➝ €36.00
10/26/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target€57.95 ➝ €51.80
10/10/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
7/29/2022DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
7/29/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
6/22/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$34.00 ➝ $27.00+14.55%
3/1/2022Oddo Bhf
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Oliver Metzger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform€72.00
2/25/2022Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target€61.00 ➝ €57.00
11/23/2021HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold
11/17/2021Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform$42.00 ➝ $35.00+6.90%
5/12/2021Nord/LB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
2/4/2021BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
2/4/2021Exane BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
2/4/2021Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
2/3/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeConviction-Buy ➝ Buy
2/1/2021Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
5/21/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$46.00 ➝ $48.00+17.10%
2/21/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$38.00 ➝ $46.00+12.28%
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












FMS Price Target - Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Fresenius Medical Care AG & Co. KGaA stock is Hold based on the current 2 sell ratings, 6 hold ratings and 1 buy rating for FMS. The average twelve-month price prediction for Fresenius Medical Care AG & Co. KGaA is $30.35 with a high price target of $33.70 and a low price target of $27.00. Learn more on FMS's analyst rating history.

Do Wall Street analysts like Fresenius Medical Care AG & Co. KGaA more than its competitors?

Analysts like Fresenius Medical Care AG & Co. KGaA less than other Medical companies. The consensus rating for Fresenius Medical Care AG & Co. KGaA is Hold while the average consensus rating for medical companies is Buy. Learn more on how FMS compares to other companies.

Do MarketBeat users like Fresenius Medical Care AG & Co. KGaA more than its competitors?

MarketBeat users like Fresenius Medical Care AG & Co. KGaA less than other Medical companies. 53.39% of MarketBeat users gave Fresenius Medical Care AG & Co. KGaA an outperform vote while medical companies recieve an average of 66.39% outperform votes by MarketBeat users.

Is Fresenius Medical Care AG & Co. KGaA being downgraded by Wall Street analysts?

Over the previous 90 days, Fresenius Medical Care AG & Co. KGaA's stock had 2 downgrades by analysts.

Does Fresenius Medical Care AG & Co. KGaA's stock price have much upside?

According to analysts, Fresenius Medical Care AG & Co. KGaA's stock has a predicted upside of 37.55% based on their 12-month price targets.

What analysts cover Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA has been rated by Barclays, Berenberg Bank, Credit Suisse Group, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., and Morgan Stanley in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:FMS) was last updated on 11/28/2022 by MarketBeat.com Staff